Investigation of the Regulation of Retinal and Choroidal Blood Vessels in Various AL Based on WF SS-OCTA Detection With Changes in Body Position
1 other identifier
observational
60
0 countries
N/A
Brief Summary
This prospective observational study aims to understand the effects of different subaxial body positions on choroidal and retinal blood vessel density. The main questions it aims to answer are as follows:1) How do retinal and choroidal blood vessels adjust and repair after changes in body position?2) Is the change of body position related to the factors that cause myopia? 3) Are there any differences in the regulation ability of fundus blood vessels in people with different ocular axes under the condition of changes in body position?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2024
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 1, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedStudy Start
First participant enrolled
October 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedSeptember 19, 2024
September 1, 2024
11 months
September 1, 2024
September 4, 2024
Conditions
Outcome Measures
Primary Outcomes (5)
Retinal blood flow density
Two modes of SS-OCTA will be used for scanning, one is the wide-angle range of 24mm\*20mm grid for quantitative analysis of choroidal and retinal vascular density. The other is a scanning range of 12mm\*12mm mode, and the choroidal thickness, choroidal vascular volume ratio, and the area and perimeter of the macular avascular zone will be analysed.
During the procedure
Intraocular pressure
iCare handheld contact tonometer wIll be used to measure the intraocular pressure of the subjects
During the procedure
Choroidal blood flow density
Two modes of SS-OCTA will be used for scanning, one is the wide-angle range of 24mm\*20mm grid for quantitative analysis of choroidal and retinal vascular density. The other is a scanning range of 12mm\*12mm mode, and the choroidal thickness, choroidal vascular volume ratio, and the area and perimeter of the macular avascular zone will be analysed.
During the procedure
Choroidal thickness
Two modes of SS-OCTA will be used for scanning, one is the wide-angle range of 24mm\*20mm grid for quantitative analysis of choroidal and retinal vascular density. The other is a scanning range of 12mm\*12mm mode, and the choroidal thickness, choroidal vascular volume ratio, and the area and perimeter of the macular avascular zone will be analysed.
During the procedure
Foveal avascular zone area
Two modes of SS-OCTA will be used for scanning, one is the wide-angle range of 24mm\*20mm grid for quantitative analysis of choroidal and retinal vascular density. The other is a scanning range of 12mm\*12mm mode, and the choroidal thickness, choroidal vascular volume ratio, and the area and perimeter of the macular avascular zone will be analysed.
During the procedure
Secondary Outcomes (1)
Axial length
Baseline, pre-procedure
Study Arms (2)
Normal axial length grooup
At the screening stage, the axial length of the subjects was measured by IOL master 700. If the other conditions were met, the subjects would be included in this group If the axial length is between 23mm and 24mm.
Long axial group
At the screening stage, the axial length of the subjects was measured by IOL master 700. If the other conditions were met, the subjects would be included in this group if the axial length is greater than 24mm.
Eligibility Criteria
Healthy people in Chengdu City will be recruited through advertisement, and those who meet the inclusion and exclusion criteria will enter the study.
You may qualify if:
- Corrected visual acuity ≥1.0 (international standard visual acuity chart);
- Age 10-40 years old;
- In good health;
- Give informed consent and volunteer for the study. The process of obtaining informed consent complies with GCP regulations.
You may not qualify if:
- Can not cooperate with the completion of relevant inspection and data collection;
- Pregnant and lactating women;
- Patients with amblyopia, glaucoma, retinitis pigmentosa, senile macular degeneration, retinal artery obstruction, retinal vein obstruction, diabetic retinopathy and other eye diseases that may affect the blood circulation and vascular diameter of the retina and vein, or those who have undergone intraocular surgery;
- Patients with cardiovascular and cerebrovascular diseases, endocrine diseases, autoimmune diseases;
- Long history of smoking and drinking;
- History of ocular trauma;
- The mentally ill;
- Those who have taken drugs that affect blood circulation in the past 3 months;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 1, 2024
First Posted
September 19, 2024
Study Start
October 1, 2024
Primary Completion
September 1, 2025
Study Completion
October 1, 2025
Last Updated
September 19, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share